American Society of Clinical Oncology Guidance Statement: The Cost of Cancer Care

Neal J. Meropol(Flatiron Health (United States)), Lowell E. Schnipper(Fox Chase Cancer Center), Peter A. Ubel(Duke University), Thomas J. Smith(Sidney Kimmel Cancer Center), Deborah Schrag(Dana-Farber Brigham Cancer Center), Robert M. Langdon(Sidney Kimmel Cancer Center), Diane Blum(Sidney Kimmel Cancer Center), Therese M. Mulvey(Sidney Kimmel Cancer Center)
Journal of Clinical Oncology
July 7, 2009
10.1200/jco.2009.23.1183
Cited by 635

Related Papers

How To Build and Interpret a Nomogram for Cancer Prognosis
|Journal of Clinical Oncology|2008|3.4k
Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial
|Journal of Clinical Oncology|2015|2.6k
Diagnosis and Treatment of Metastatic Colorectal Cancer
|JAMA|2021|2.6k
Overall Survival Results of a Trial Assessing Patient-Reported Outcomes for Symptom Monitoring During Routine Cancer Treatment
|JAMA|2017|2.3k
Bevacizumab in Combination With Oxaliplatin, Fluorouracil, and Leucovorin (FOLFOX4) for Previously Treated Metastatic Colorectal Cancer: Results From the Eastern Cooperative Oncology Group Study E3200
|Journal of Clinical Oncology|2007|2.3k